SCHEMBL6567345

SCHEMBL6567345

NC(=O)C(OCc1ccccc1)C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.56
SLC1A2 P43004 2/20 0.56
SLC1A1 P43005 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
PARP10 Q53GL7 1/20 0.47
EPHX1 P07099 1/20 0.47
ALDH1A1 P00352 3/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
IDO1 P14902 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27978224 0.89 ALDH1A1 (0.50) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL3583575 0.84 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL1231110 0.83 SLC1A1 (0.59) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL18925989 0.82 SLC1A1 (0.59) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL3581960 0.82 SPHK2 (0.46) SLC1A3SLC1A2SLC1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9760378 0.82 SLC1A1 (0.58) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL376695 0.81 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL18381513 0.81 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL204704 0.81 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL26963671 0.81 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-1204652-A1 NOVEL SUCCINATE DERIVATIVE COMPOUNDS USEFUL AS CYSTEINE PROTEASE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2002-05-15 EP disclosed
WO-2001009110-A1 NOVEL SUCCINATE DERIVATIVE COMPOUNDS USEFUL AS CYSTEINE PROTEASE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-02-08 WO disclosed
CN-1234031-A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF) PFIZER (US) 1999-11-03 CN disclosed